Location History:
- North Brunswick, NJ (US) (2002 - 2005)
- Milltown, NJ (US) (2009 - 2017)
Company Filing History:
Years Active: 2002-2017
Title: The Innovative Contributions of Ernst Schramm
Introduction
Ernst Schramm is a notable inventor based in Milltown, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, Schramm has made remarkable advancements, particularly in the area of radioisotope generators.
Latest Patents
Among his latest patents, Schramm has developed innovative containers for pharmaceuticals, specifically designed for use in radioisotope generators. One of his inventions includes a radioisotope generator system that features a column assembly with an inlet arm and an outlet arm. This column contains packing material that binds a radioisotope and defines a notch between an open area and a stopper receptacle area, where the outlet arm's opening is positioned. Additionally, the system incorporates a Luer lock connection between the outlet arm and connector tubing, ensuring a secure and non-leaking lock through the alignment of male and female Luer caps. Another patent focuses on improved containers for pharmaceuticals that are subjected to irradiation, heating, or increased pressure, particularly for use in a rubidium-82 generator.
Career Highlights
Throughout his career, Schramm has worked with prominent companies such as Bracco Diagnostics Inc. and Bracco International Bv. His work has significantly impacted the pharmaceutical industry, particularly in the development of safe and effective delivery systems for radioisotopes.
Collaborations
Schramm has collaborated with esteemed colleagues, including Ernest Balestracci and Julius P. Zodda, contributing to the advancement of innovative solutions in his field.
Conclusion
Ernst Schramm's contributions to the field of pharmaceuticals, particularly through his patents related to radioisotope generators, highlight his role as a significant inventor. His work continues to influence the industry, ensuring safer and more effective pharmaceutical delivery systems.